GREY:CLAZF - Post by User
Comment by
Jmk2454on Aug 13, 2019 1:55pm
74 Views
Post# 30022871
RE:RE:RE:RE:RE:RE:RE:RE:Volume
RE:RE:RE:RE:RE:RE:RE:RE:VolumeBelgiumboy wrote: JMark80 wrote: October sounds about right. On another topic, if phase 2 was pivotal (perhaps with market surveillance) would they even need a marketing partner? Not too difficult to sell a drug that doesn't have any competition. Besides, isn't that a reason why they are acquiring a CBD extraction company?
Jmk, these are things I've also been thinking about in the last weeks. Indeed, chances are they won't even need a partnerschip. In my opinion the FDA themselves want this to be approved as soon as possible because it's a safe remedy and the research outcomes are extremely well. In this case the share price would go to the stars and I think that's very possible!
I totally agree with you. Maybe the FDA is currently working with them to get the fast track and breakthrough therapy (I think those are the two) approval in place and then as soon as 2b is done in October they could start marketing. Could it happen that quickly? We know when this goes it’s going to go fast.
Isn’t this board great today? Having real discussions without distractions? Although I had put certain posters on ignore so maybe nobody is responding to them - I thought I read they were gone again though.